Consuelo Buttigliero

16PUBLICATIONS
89CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsClinical pharmacology and therapeuticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Jan 28, 2026
Long-Term Oncological Outcomes in Metastatic Prostate Cancer Patients Who Are Able to Maintain/Recover Ongoing Anticancer Therapy After SARS-CoV-2 Infection-Results of the MEET-URO 22 Study.

Orazio Caffo, Umberto Basso, Antonello Veccia

|Jul 12, 2025
Is [177Lu]Lu-PSMA-617 Redefining Value in mCRPC Care? A Meta-Analysis of Clinical and Economic Endpoints.

Francesco Fiorica, Maria Viviana Candela, Teodoro Sava

|Apr 26, 2025
Metastasis-Directed Therapy in Oligometastatic Prostate Cancer: Biological Rationale and Systematic Review of Published Data.

Francesco Fiorica, Teodoro Sava, Jacopo Giuliani

|Aug 28, 2024
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis.

Giovanni Farinea, Mariangela Calabrese, Federica Carfì

|Jan 23, 2024
Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma.

Alessandro Samuelly, Rosario Francesco Di Stefano, Fabio Turco

Pageof 3

Frequent Collaborators

7 joint publications

Ursula Maria Vogl

4 joint publications

Orazio Caffo

3 joint publications

Ursula Maria Vogl

3 joint publications

Marco Donatello Delcuratolo